Test bank pharmacotherapeutics for advanced practice a
practical approach 5th edition by Virginia P. Arcangelo and
Peterson Chapters 1-56
n k
r a
F
, TABLE OF CONTENT
Chapter 1: Issues for the Practitioner in Drug Therapy
Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
Chapter 3: Impact of Drug Interactions and Adverse Events on Therapeutics
Chapter 4: Principles of Pharmacotherapy in Pediatrics, Pregnancy and Lactation
Chapter 5: Pharmacotherapy Principles in Older Adults
Chapter 6: Principles of Antimicrobial Therapy
Chapter 7: Pharmacogenomics
Chapter 8: The Economics of Pharmacotherapeutics
Chapter 9: Principles of Pharmacology in Pain Management
k
Chapter 10: Pain Management in Opioid Use Disorder (OUD) Patients
n
Chapter 11: Cannabis and Pain Managementa
Chapter 12: Dermatitis
Chapter 13: Bacterial, Fungal, and Viral Infections of the Skin
r F
Chapter 14: Psoriasis
Chapter 15: Acne Vulgaris and Rosacea
Chapter 16: Ophthalmic Disorders
Chapter 17: Otitis Media and Otitis Externa
Chapter 18: Hypertension
Chapter 19: Hyperlipidemia
Chapter 20: Chronic Stable Angina and Myocardial Infarction
Chapter 21: Heart Failure
Chapter 22: Arrhythmias
Chapter 23: Respiratory Infections
Chapter 24: Asthma and Chronic Obstructive Pulmonary Disease
Chapter 25: Gastric, Functional and Inflammatory Bowel Disorders
Chapter 26: Gastroesophageal Reflux Disease and Peptic Ulcer Disease
Chapter 27: Liver Diseases
, Chapter 28: Urinary Tract Infection
Chapter 29: Prostatic Disorders and Erectile Dysfunction
Chapter 30: Overactive Bladder
Chapter 31: Sexually Transmitted Infections
Chapter 32: Osteoarthritis and Gout
Chapter 33: Osteoporosis
Chapter 34: Rheumatoid Arthritis
Chapter 35: Headaches
Chapter 36: Seizure Disorders
Chapter 37: Alzheimer’s Disease
k
Chapter 38: Parkinson Disease
Chapter 39: Major Depressive Disorder and Bipolar Disorders
n
Chapter 40: Anxiety Disorders
a
Chapter 41: Sleep Disorders
r
Chapter 42: Attention Deficit Hyperactivity Disorder
F
Chapter 43: Substance Use Disorders
Chapter 44: Diabetes Mellitus
Chapter 45: Thyroid and Parathyroid Disorders
Chapter 46: Allergies and Allergic Reactions
Chapter 47: Human Immunodeficiency Virus
Chapter 48: Organ Transplantation
Chapter 49: Pharmacotherapy for Select Thromboembolic Disorders
Chapter 50: Anemias
Chapter 51: Immunizations
Chapter 52: Smoking Cessation
Chapter 53: Weight Loss
Chapter 54: Contraception
Chapter 55: Menopause
Chapter 56: Vaginitis
, Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Answer: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
Answer: D PTS: 1
k
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
n
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
a
D. Prescribing all generic medications to cut costs
Answer: A PTS: 1
r
4. Criteria for choosing an effective drug for a disorder include:
F
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
Answer: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
Answer: A PTS: 1
practical approach 5th edition by Virginia P. Arcangelo and
Peterson Chapters 1-56
n k
r a
F
, TABLE OF CONTENT
Chapter 1: Issues for the Practitioner in Drug Therapy
Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
Chapter 3: Impact of Drug Interactions and Adverse Events on Therapeutics
Chapter 4: Principles of Pharmacotherapy in Pediatrics, Pregnancy and Lactation
Chapter 5: Pharmacotherapy Principles in Older Adults
Chapter 6: Principles of Antimicrobial Therapy
Chapter 7: Pharmacogenomics
Chapter 8: The Economics of Pharmacotherapeutics
Chapter 9: Principles of Pharmacology in Pain Management
k
Chapter 10: Pain Management in Opioid Use Disorder (OUD) Patients
n
Chapter 11: Cannabis and Pain Managementa
Chapter 12: Dermatitis
Chapter 13: Bacterial, Fungal, and Viral Infections of the Skin
r F
Chapter 14: Psoriasis
Chapter 15: Acne Vulgaris and Rosacea
Chapter 16: Ophthalmic Disorders
Chapter 17: Otitis Media and Otitis Externa
Chapter 18: Hypertension
Chapter 19: Hyperlipidemia
Chapter 20: Chronic Stable Angina and Myocardial Infarction
Chapter 21: Heart Failure
Chapter 22: Arrhythmias
Chapter 23: Respiratory Infections
Chapter 24: Asthma and Chronic Obstructive Pulmonary Disease
Chapter 25: Gastric, Functional and Inflammatory Bowel Disorders
Chapter 26: Gastroesophageal Reflux Disease and Peptic Ulcer Disease
Chapter 27: Liver Diseases
, Chapter 28: Urinary Tract Infection
Chapter 29: Prostatic Disorders and Erectile Dysfunction
Chapter 30: Overactive Bladder
Chapter 31: Sexually Transmitted Infections
Chapter 32: Osteoarthritis and Gout
Chapter 33: Osteoporosis
Chapter 34: Rheumatoid Arthritis
Chapter 35: Headaches
Chapter 36: Seizure Disorders
Chapter 37: Alzheimer’s Disease
k
Chapter 38: Parkinson Disease
Chapter 39: Major Depressive Disorder and Bipolar Disorders
n
Chapter 40: Anxiety Disorders
a
Chapter 41: Sleep Disorders
r
Chapter 42: Attention Deficit Hyperactivity Disorder
F
Chapter 43: Substance Use Disorders
Chapter 44: Diabetes Mellitus
Chapter 45: Thyroid and Parathyroid Disorders
Chapter 46: Allergies and Allergic Reactions
Chapter 47: Human Immunodeficiency Virus
Chapter 48: Organ Transplantation
Chapter 49: Pharmacotherapy for Select Thromboembolic Disorders
Chapter 50: Anemias
Chapter 51: Immunizations
Chapter 52: Smoking Cessation
Chapter 53: Weight Loss
Chapter 54: Contraception
Chapter 55: Menopause
Chapter 56: Vaginitis
, Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Answer: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
Answer: D PTS: 1
k
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
n
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
a
D. Prescribing all generic medications to cut costs
Answer: A PTS: 1
r
4. Criteria for choosing an effective drug for a disorder include:
F
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
Answer: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
Answer: A PTS: 1
